VACC

Vaccitech plc VACC

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VACC LSB THRX SPPI ZVRA TCRT LENZ FSTX CRGX SLRN
6M 103.25 % -51.02 % 38.74 % 31.75 % 53.89 % 9.80 % 12.94 % 16.15 % 17.63 % -27.94 %
YTD 108.33 % -82.63 % 1.63 % 167.97 % 26.48 % 36.55 % 8.91 % 15.40 % -70.30 % -31.21 %
1Y 117.39 % -78.38 % -47.95 % -10.87 % 37.64 % 30.58 % 8.11 % 100.00 % -81.53 % -42.96 %
3Y -64.54 % -99.37 % -78.12 % -75.65 % 95.07 % -98.49 % 81.34 % 667.24 % -69.24 % -87.39 %
5Y -64.54 % -99.34 % -78.12 % -95.47 % 13.52 % -99.19 % -64.81 % -49.50 % -69.24 % -87.39 %
10Y -64.54 % -99.34 % -78.12 % -86.62 % -95.54 % -99.85 % -64.81 % -35.86 % -69.24 % -87.39 %
From the beginning -64.54 % -99.34 % -78.12 % -99.25 % -93.82 % -99.89 % -64.81 % -35.86 % -69.24 % -87.39 %

Dividend

Theseus Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

LENZ Therapeutics, Inc.